RAD-140 Testolone Sarm
RAD-140 Testolone is an Investigational Selective Androgen Receptor Modulator developed in collaboration with the Food and Drug Administration (FDA). It is believed that RAD-140 could reduce or prevent the onset of benign prostatic hyperplasia (BPH) in men by acting on the male sex hormone testosterone.
Testosterone (testosterone) has been known to increase prostate cancer, increase body hair and cause other health conditions. RAD works by binding the male sex hormone testosterone, preventing it from binding to the receptor sites in the prostate.
When RAD-140 binds with the receptor sites in the prostate, the binding is unable to occur. This results in increased levels of androgens in the prostate.
Molecular Formula: C20H16ClN5O2
Molecular Weight: 393.8 g/mol
All products listed on this website and provided through Pharma Labs Global are intended for medical research purposes only. Pharma Lab Global does not encourage or promote the use of any of these products in a personal capacity (i.e. human consumption), nor are the products intended to be used as a drug, stimulant or for use in any food products.